Ingrid Øra Selected Research

endothelial PAS domain-containing protein 1

5/2002

Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingrid Øra Research Topics

Disease

21	Neoplasms (Cancer) 01/2024 - 05/2002
9	Neuroblastoma 01/2022 - 07/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 02/2024
2	Glioma (Gliomas) 01/2024 - 01/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2011
2	Ganglioneuroma 05/2009 - 04/2008
2	Hypoxia (Hypoxemia) 07/2003 - 05/2002
1	Hyperemia 02/2024
1	Rhabdomyosarcoma 01/2024
1	Sarcoma (Soft Tissue Sarcoma) 01/2024
1	Diffuse Intrinsic Pontine Glioma 01/2024
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Central Nervous System Neoplasms 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2021
1	COVID-19 12/2020
1	Fatigue 04/2020
1	Wilms Tumor (Wilm's Tumor) 08/2016
1	Osteosarcoma (Osteogenic Sarcoma) 08/2016
1	Ewing Sarcoma (Sarcoma, Ewing) 08/2016
1	Clear Cell Sarcoma 02/2015
1	Kidney Neoplasms (Kidney Cancer) 01/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2014
1	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 09/2013
1	Infections 09/2013
1	Ganglion Cysts (Ganglion) 07/2013
1	Leukemia 04/2013
1	Chromosomal Instability (Chromosome Stability) 04/2011
1	Anaplasia 11/2010
1	Ganglioneuroblastoma 05/2009
1	Acute Promyelocytic Leukemia 05/2004

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 02/2024 - 05/2002
4	Messenger RNA (mRNA)IBA 04/2014 - 05/2009
3	RNA (Ribonucleic Acid)IBA 01/2023 - 09/2013
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 02/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2011
2	larotrectinibIBA 01/2022 - 01/2021
2	Hormones (Hormone)IBA 02/2019 - 08/2016
2	Arsenic Trioxide (Trisenox)FDA Link 02/2007 - 05/2004
1	CeramidesIBA 03/2024
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	LeptinIBA 02/2024
1	dipinacoline glutamateIBA 01/2024
1	CateninsIBA 01/2023
1	SynaptophysinIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2022
1	nutlin 3IBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	abemaciclibIBA 01/2022
1	TropomyosinIBA 01/2022
1	ribociclibIBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2015
1	3-Iodobenzylguanidine (Iobenguane)IBA 02/2015
1	EnzymesIBA 09/2013
1	N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA 09/2013
1	inhibin BIBA 04/2013
1	MicroRNAs (MicroRNA)IBA 10/2011
1	Heparin (Liquaemin)FDA LinkGeneric 01/2011
1	Ion Channels (Ion Channel)IBA 11/2010
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 05/2009
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 05/2009
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2009
1	beta CateninIBA 04/2008
1	NBPhox proteinIBA 02/2008
1	Aligeron (AS 2)IBA 05/2004
1	Differentiation AntigensIBA 07/2003
1	Oxygen (Dioxygen)IBA 05/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2002
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 05/2002
1	endothelial PAS domain-containing protein 1IBA 05/2002

Therapy/Procedure

6	Therapeutics 01/2024 - 02/2007
4	Drug Therapy (Chemotherapy) 01/2021 - 02/2007
2	Aftercare (After-Treatment) 04/2020 - 08/2016
2	Radiotherapy 08/2016 - 04/2013
1	Investigational Therapies (Experimental Therapy) 12/2020
1	Stem Cell Transplantation 09/2013
1	Maintenance Chemotherapy 04/2013